<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cancer Prev</journal-id>
<journal-id journal-id-type="iso-abbrev">J Cancer Prev</journal-id>
<journal-id journal-id-type="publisher-id">JCP</journal-id>
<journal-title-group>
<journal-title>Journal of Cancer Prevention</journal-title>
</journal-title-group>
<issn pub-type="ppub">2288-3649</issn>
<issn pub-type="epub">2288-3657</issn>
<publisher>
<publisher-name>Korean Society of Cancer Prevention</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30370256</article-id>
<article-id pub-id-type="pmc">6197845</article-id>
<article-id pub-id-type="doi">10.15430/JCP.2018.23.3.117</article-id>
<article-id pub-id-type="publisher-id">jcp-23-117</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Effect of Microbiota on Colon Carcinogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yoon</surname>
<given-names>Kichul</given-names>
</name>
<xref ref-type="aff" rid="af1-jcp-23-117">1</xref>
<xref ref-type="aff" rid="af2-jcp-23-117">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kim</surname>
<given-names>Nayoung</given-names>
</name>
<xref ref-type="aff" rid="af1-jcp-23-117">1</xref>
<xref ref-type="aff" rid="af3-jcp-23-117">3</xref>
</contrib>
</contrib-group>
<aff id="af1-jcp-23-117">
<label>1</label>Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 
<country>Korea</country></aff>
<aff id="af2-jcp-23-117">
<label>2</label>Department of Internal Medicine and Digestive Disease Research Institute, Wonkwang University Sanbon Hospital, Gunpo, 
<country>Korea</country></aff>
<aff id="af3-jcp-23-117">
<label>3</label>Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 
<country>Korea</country></aff>
<author-notes>
<corresp id="c1-jcp-23-117">Correspondence to: Nayoung Kim, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea, Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-mail: <email>nayoungkim49@empas.com</email>, ORCID: Nayoung Kim, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9397-0406">https://orcid.org/0000-0002-9397-0406</ext-link></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>23</volume>
<issue>3</issue>
<fpage>117</fpage>
<lpage>125</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Korean Society of Cancer Prevention</copyright-statement>
<copyright-year>2018</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Although genetic background is known to contribute to colon carcinogenesis, the exact etiology of the disease remains elusive. The organ’s extensive interaction with microbes necessitated research on the role of microbiota on development of colon cancer. In this review, we summarized the defense mechanism of colon from foreign organism, and germ-free animal models that have been employed to elucidate microbial effect. We also comprehensively discussed the metabolic property of microbiota such as butyrate production, facilitation of heme toxicity, bile acid transformation, and nitrate reduction that has been shown to contribute to the development of the tumor. Finally, up-to-date subjects such as the effect of age and gender on microbiota are briefly discussed.</p>
</abstract>
<kwd-group>
<kwd>Microbiota</kwd>
<kwd>Colon</kwd>
<kwd>Carcinogenesis</kwd>
<kwd>Butyric acid</kwd>
<kwd>Bile acids and salts</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>According to the International Agency for Research on Cancer estimates, in 2012, colorectal cancer accounted for 9.7% of all incident cancers in the world with 1.4 million cases and 694,000 deaths. That makes it the third most common cancer in men and the second in women.<xref ref-type="bibr" rid="b1-jcp-23-117">1</xref>,<xref ref-type="bibr" rid="b2-jcp-23-117">2</xref> The human gastrointestinal tract represents one of the largest interfaces (250–400 m<sup>2</sup>) between the host, environmental factors and antigens in the human body.<xref ref-type="bibr" rid="b3-jcp-23-117">3</xref> The dense communities of bacteria in the lower intestine (≥ 10<sup>12</sup>/cm<sup>3</sup>) are separated from body tissues by the epithelial layer (10 μm) over the surface area.<xref ref-type="bibr" rid="b4-jcp-23-117">4</xref> Human intestinal microbiota is composed of 10<sup>13</sup> to 10<sup>14</sup> microorganisms with microbiome (collective genome) of at least 100 times as many genes as our own genome.<xref ref-type="bibr" rid="b5-jcp-23-117">5</xref> According to revised estimates, the number of bacteria in the body is about the same order as the number of human cells, and their total mass is about 0.2 kg.<xref ref-type="bibr" rid="b6-jcp-23-117">6</xref> This microbiome encompasses all genes for processes, such as substrate breakdown, protein synthesis, biomass production, production of signaling molecules, and antimicrobial compounds.<xref ref-type="bibr" rid="b7-jcp-23-117">7</xref> It also encodes biochemical pathways that humans have not evolved.<xref ref-type="bibr" rid="b7-jcp-23-117">7</xref> The intestinal microbiota can therefore be regarded as a separate organ within the human host, that is capable of even more conversions than the human liver.<xref ref-type="bibr" rid="b8-jcp-23-117">8</xref> There is mounting evidence that dysbiosis, a state of pathological imbalance in the gut microbiome is present in many disease states, including colorectal neoplasm.<xref ref-type="bibr" rid="b9-jcp-23-117">9</xref> In addition, there are many articles that published the effect of sex hormone, aging and fungi on the colon cancer. However, there have been few comprehensive review articles regarding the effect of microbiota on the colorectal neoplasm. From this background we tried to summarize the metabolic factors such as bile acid and butyrate which affect colon carcinogenesis in terms of the microbiota.</p>
</sec>
<sec>
<title>COLORECTAL NEOPLASM</title>
<p>The widely accepted classic model for colorectal tumorigenesis suggests that at least 5 to 7 major molecular alterations are needed to occur for a normal epithelial cell to proceed to carcinoma.<xref ref-type="bibr" rid="b10-jcp-23-117">10</xref> The colorectal tissue environment is unique in that the intestinal mucosal surface is continuously exposed to a vast community of microorganisms.<xref ref-type="bibr" rid="b11-jcp-23-117">11</xref> Bacteria have been linked to colorectal cancer by production of toxic and genotoxic bacterial metabolites which can bind specific cell surface receptors and affect intracellular signal transduction.<xref ref-type="bibr" rid="b12-jcp-23-117">12</xref> A large body of evidence supports a relationship between infective agents and human cancers and suggests that certain mucosa-associated bacterial species play an important role in the pathogenesis of colorectal cancer<xref ref-type="bibr" rid="b12-jcp-23-117">12</xref>,<xref ref-type="bibr" rid="b13-jcp-23-117">13</xref> A recent human study further reported the complex mechanism of colonic carcinogenesis regarding microbiota with the difference in colitis associated cancer and sporadic cancer.<xref ref-type="bibr" rid="b14-jcp-23-117">14</xref> General mechanisms for microbiota-related colon cancer is summarized in <xref ref-type="fig" rid="f1-jcp-23-117">Figure 1</xref>.<xref ref-type="bibr" rid="b15-jcp-23-117">15</xref></p>
</sec>
<sec>
<title>DEFENSE MECHANISM OF COLON</title>
<p>In a mouse model of colon, two distinct layers of mucus were found. The firm mucus layer of colon is dense and has a high mucin2 (Muc2) concentration.<xref ref-type="bibr" rid="b16-jcp-23-117">16</xref> Probably according to the physical blockage of small sized pores, the inner layer doesn’t carry bacteria. In contrast, the ‘movable’ outer layer which is colonized by bacteria has an expanded volume from the proteolytic cleavages of the Muc2.<xref ref-type="bibr" rid="b16-jcp-23-117">16</xref> Mucosal compartmentalization functions to minimize exposure of resident bacteria to the systemic immune system.<xref ref-type="bibr" rid="b4-jcp-23-117">4</xref> Typically, commensal microorganisms that penetrate the intestinal epithelial cell barrier are phagocytosed and eliminated by lamina propria macrophages.<xref ref-type="bibr" rid="b17-jcp-23-117">17</xref></p>
<p>Human mucosal barrier mainly consists of conventional colonic epithelial cells. Epithelial cells are maintained on a network of interconnected myofibroblasts. Goblet cells are important for producing both mucus and trefoil peptides, and enteroendocrine cells produce paracrine molecules.<xref ref-type="bibr" rid="b18-jcp-23-117">18</xref> The intraepithelial diffuse lymphocytes, intramucosal and submucosal follicles and patches form the barrier against organisms, such as bacteria, viruses, parasites and fungi.<xref ref-type="bibr" rid="b18-jcp-23-117">18</xref>,<xref ref-type="bibr" rid="b19-jcp-23-117">19</xref></p>
<p>Innate immunity is the basic mechanism of mucosal defense. Pattern recognition receptors such as Toll-like receptors enables mammalian cells to recognize conserved characteristic molecules on microorganisms and they are known as pathogen-associated molecular patterns.<xref ref-type="bibr" rid="b18-jcp-23-117">18</xref>,<xref ref-type="bibr" rid="b20-jcp-23-117">20</xref> Bacteria and their products affects the gut permeability to antigen.<xref ref-type="bibr" rid="b21-jcp-23-117">21</xref> Epithelial cytokines are influenced by factors in the luminal microflora and they regulate the status of local T cells, B cells macrophages and polymorphs.<xref ref-type="bibr" rid="b21-jcp-23-117">21</xref></p>
<p>While the immune system prevents microbial colonization, it paradoxically facilitates the establishment of gut microbiota.<xref ref-type="bibr" rid="b22-jcp-23-117">22</xref> Specifically, immunoglobulin A (IgA) has been suggested to help bacterial adherence to intestinal epithelial cells.<xref ref-type="bibr" rid="b22-jcp-23-117">22</xref> Donaldson et al.<xref ref-type="bibr" rid="b22-jcp-23-117">22</xref> recently reported the IgA-enhanced colonization on mucosa for the species of gut microbiome including the multiple strains of <italic>Bacteroides fragilis</italic>.</p>
</sec>
<sec>
<title>GERM-FREE ANIMAL MODEL</title>
<p>Germ-free animal models have been employed to investigate the interaction between gut microbiota and host in carcinogenesis. Gut commensal microbes colonizing neonatal mammals increase specific and natural antibodies against the microbiota, thereby affecting the immune system development.<xref ref-type="bibr" rid="b23-jcp-23-117">23</xref> When carcinogens such as 1,2-dimethylhydrazine (DMH) and azoxymethane (AOM) were administered, DMH induced colonic tumors in 20% of germ-free rats and in 93% of conventional rats.<xref ref-type="bibr" rid="b24-jcp-23-117">24</xref> AOM increased the multiplicity of colonic tumors in germ-free and gnotobiotic rats contaminated with <italic>Clostridium perfringens</italic>, as compared to conventional Rats.<xref ref-type="bibr" rid="b24-jcp-23-117">24</xref></p>
<p>Vannucci et al.<xref ref-type="bibr" rid="b19-jcp-23-117">19</xref> performed subcutaneous injection of carcinogen AOM and promoter porcine bile to germ-free and conventional rats. They found that germ free rats showed a lower susceptibility to induction and development of colorectal cancers, and a more active anticancer immune response than conventional rats.<xref ref-type="bibr" rid="b19-jcp-23-117">19</xref> Germ-free rats showed enhanced immunity represented by natural-killer cells and natural-killer T (NKT) lymphocytes, and increased number and augmented function of both cytotoxic T cell and B cells, while conventional rats had increased T, T helper and NKT cells and a reduction in B lymphocytes.<xref ref-type="bibr" rid="b19-jcp-23-117">19</xref> They hypothesized that immunological activation to commensal microflora may increase the spectrum of tolerance to antigens, thereby impeding the host’s anticancer response.<xref ref-type="bibr" rid="b19-jcp-23-117">19</xref></p>
<p>T-cell receptor β chain and p53 double-knockout mice (TCR<sup>−−</sup> p53<sup>−−</sup>) shows high incidence of spontaneous colorectal cancer.<xref ref-type="bibr" rid="b25-jcp-23-117">25</xref> Kado et al.<xref ref-type="bibr" rid="b26-jcp-23-117">26</xref> conducted a study to investigate the role of intestinal microflora for development of adenocarcinoma in the p53 double-knockout mouse model. In conventional mice, adenocarcinomas of ileocecum and cecum were detected in 70% of animals. In contrast, in grem-free mice, the development of adenocarcinoma was completely suppressed.<xref ref-type="bibr" rid="b26-jcp-23-117">26</xref></p>
<p>On the other hand in familial adenomatous polyposis mouse model (C57BL/6-Apc<sup>Min/+</sup>), there was no significant difference in development of adenoma in the intestine between germ-free mice and conventional animals.<xref ref-type="bibr" rid="b27-jcp-23-117">27</xref> However, a recent report by Tomkovich et al.<xref ref-type="bibr" rid="b28-jcp-23-117">28</xref> employing germ-free, specific-pathogen-free and gnotobiotic Apc<sup>Min/+</sup>;Il10<sup>−−</sup> mice model found that the colon tumorigenesis was related to inflammation. They showed that tumor was practically abolished in germ-free Apc<sup>Min/+</sup>;Il10<sup>−−</sup> and pks<sup>+</sup>
<italic>Escherichia coli</italic> promoted tumorigenesis in the Apc<sup>Min/+</sup>;Il10<sup>−−</sup> model in a colibactin-dependent manner.<xref ref-type="bibr" rid="b28-jcp-23-117">28</xref></p>
<p>The role of microflora on the development of intestinal neoplasm varied according to the genetic background. According to aforementioned studies employing germ-free animals, there have been a trend that conventional microbiota is needed for carcinogenesis especially in sporadic colon cancer model.</p>
</sec>
<sec>
<title>METABOLIC PROPERTY OF MICROBIOTA IN TUMORIGENESIS</title>
<p>Metabolic property of gut bacterial population has been investigated in relation to tumorigenesis. Specific metabolic processes and products are discussed here (<xref ref-type="fig" rid="f2-jcp-23-117">Fig. 2</xref>).<xref ref-type="bibr" rid="b29-jcp-23-117">29</xref></p>
<sec>
<title>1. Butyrate</title>
<p>Colon microbiota depends on the dietary residues that avoided the digestion and absorption.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref> Typically, dietary fibers are fermented by microbiota of large intestine because they are not degraded and absorbed in the small intestine.<xref ref-type="bibr" rid="b31-jcp-23-117">31</xref> Consumption of a balanced diet predominantly yields carbohydrate residues such as fiber, which stimulates saccharolytic fermentation and the production of short-chain fatty acids (SFCAs). Bacteria with an almost exclusive saccharolytic metabolism are generally considered to be beneficial because of their metabolic function and end products. Such a metabolic function is typical for lactobacilli and bifidobacteria.<xref ref-type="bibr" rid="b31-jcp-23-117">31</xref> Among SCFAs, butyrate has been investigated extensively.</p>
<sec>
<title>1) Role of butyrate</title>
<p>The SCFAs, namely acetate, butyrate, and propionate are quantitatively and metabolically the most important microbial end-products of the human colon fermentation process.<xref ref-type="bibr" rid="b29-jcp-23-117">29</xref>,<xref ref-type="bibr" rid="b32-jcp-23-117">32</xref> Among them, butyrate produced by fermentation of dietary fiber is considered to be the main reason for the health benefit from the indigestible carbohydrate.<xref ref-type="bibr" rid="b33-jcp-23-117">33</xref> Butyrate is the preferred energy source for the colonic mucosa, and all three SCFAs have antiinflammatory and antiproliferative properties.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref> Meanwhile, butyrate suppresses the growth of tumor cells. The most investigated mechanism is that butyrate inhibits histone deacetylases (HDAC) and thus results in inactivation of many oncogenic signaling pathways.<xref ref-type="bibr" rid="b34-jcp-23-117">34</xref> The metabolic rearrangement in cancerous colonocytes is an appropriate means for providing biomaterials as well as energy that are essential for growth (Warburg effect). Therefore, butyrate accumulates and functions as an HDAC inhibitor.<xref ref-type="bibr" rid="b35-jcp-23-117">35</xref> The effect of butyrate has been reported to differ according to dosage. Lower doses of butyrate have a differential effect on cell proliferation depending on the Warburg effect, while higher doses of butyrate was shown to inhibit proliferation regardless of the Warburg effect.<xref ref-type="bibr" rid="b35-jcp-23-117">35</xref> Butyrate is metabolized to acetyl-CoA, the dose of butyrate determines the utilization of epigenetic mechanisms.<xref ref-type="bibr" rid="b35-jcp-23-117">35</xref> A high dose of butyrate (5 mM) is a potent HDAC inhibitor, while at low doses such as 0.5 mM, butyrate might induce histone acetylation by an alternative mechanism that is distinct from its role as an HDAC inhibitor.<xref ref-type="bibr" rid="b35-jcp-23-117">35</xref></p>
<p>Butyrate induces cell differentiation, promotes cell apoptosis and reduces tumor cell invasiveness.<xref ref-type="bibr" rid="b36-jcp-23-117">36</xref> Human study revealed that high red meat consumption increased the levels of pro-oncogenic microRNA including miR-17-92 cluster in rectal biopsies, and increased butyrate supply through consumption of a butyrylated-resistant starch restored the miR-17-92 miRNAs to baseline levels.<xref ref-type="bibr" rid="b37-jcp-23-117">37</xref> Butyrate insufficiency may contribute to the development of inflammatory conditions because the acid has been shown to induce the differentiation of colonic T regulatory lymphocytes, which suppress inflammatory and allergic responses.<xref ref-type="bibr" rid="b38-jcp-23-117">38</xref>,<xref ref-type="bibr" rid="b39-jcp-23-117">39</xref> Gut microbial metabolite butyrate was shown to suppress development of colon carcinogenesis in Apc<sup>Min/+</sup> mice due to its Gpr109a agonist property through T regulatory cell differentiation.<xref ref-type="bibr" rid="b40-jcp-23-117">40</xref></p>
</sec>
<sec>
<title>2) Butyrate producing bacteria</title>
<p>Bifidobacteria are Gram-positive, anaerobic, saccharolytic bacteria belong to the phylum Actinobacteria.<xref ref-type="bibr" rid="b32-jcp-23-117">32</xref> Most butyrate producers in the human colon belong to the Firmicutes phylum and in particular <italic>Clostridium</italic> clusters IV and XIVa.<xref ref-type="bibr" rid="b32-jcp-23-117">32</xref> Clostridial clusters IV and XIVa butyrate producers are Gram-positive, highly oxygen-sensitive, anaerobic and saccharolytic bacteria. The two dominant bacterial species are <italic>Faecalibacterium prausnitzii</italic> (up to 14% of the total fecal microbiota, clostridial cluster IV) and <italic>Eubacterium rectale</italic> (up to 13% of the total fecal microbiota, clostridial cluster XIVa).<xref ref-type="bibr" rid="b32-jcp-23-117">32</xref>,<xref ref-type="bibr" rid="b41-jcp-23-117">41</xref> Adding a fermentable fiber (inulin) to the diet of obese women increased counts of <italic>F. prausnitzii</italic> and other clostridial bacteria and reduced systemic inflammation.<xref ref-type="bibr" rid="b42-jcp-23-117">42</xref> Pyrosequencing study revealed the difference in fecal microbial poulation patterns between colorectal cancer and healthy subjects.<xref ref-type="bibr" rid="b43-jcp-23-117">43</xref> Phylotypes closely related to Bacteroides were prevalent in the cancer patients, while the butyrate producing <italic>Faecalibacterium</italic> and <italic>Roseburia</italic> were significantly less abundant.<xref ref-type="bibr" rid="b43-jcp-23-117">43</xref> The abundance of Bacteroides species and colorectal cancer status was positively correlated.<xref ref-type="bibr" rid="b43-jcp-23-117">43</xref> Potentially pathogenic Fusobacterium and Campylobacter species were more abundant in colorectal cancer patients than in the controls.<xref ref-type="bibr" rid="b43-jcp-23-117">43</xref> A cross-sectional study measured the fecal samples from African Americans with a high risk of colon cancer and rural native Africans with a low risk for the disease.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref> Native Africans had significantly higher abundance in the butyrate-producing bacteria such as <italic>F. prausnitzii</italic>, <italic>Clostridium</italic> cluster IV, and <italic>Clostridium</italic> cluster XIVa, while Bacteroides was the dominant microbial composition of African Americans.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref></p>
</sec>
<sec>
<title>3) Controversy on butyrate</title>
<p>Although SFCAs including butyrate have been generally shown to be beneficial, several challenging reports also exist. Several key studies on the relationship between butyrate, microbiota and colon cancer are summarized on <xref ref-type="table" rid="t1-jcp-23-117">Table 1</xref>.<xref ref-type="bibr" rid="b37-jcp-23-117">37</xref>,<xref ref-type="bibr" rid="b38-jcp-23-117">38</xref>,<xref ref-type="bibr" rid="b40-jcp-23-117">40</xref>,<xref ref-type="bibr" rid="b44-jcp-23-117">44</xref>–<xref ref-type="bibr" rid="b50-jcp-23-117">50</xref></p>
<p>Higher fecal SCFA concentration correlated positively with metabolic syndrome risk factors, such as adiposity, waist circumference and homeostatic model assessment index, and inversely with high-density lipoprotein.<xref ref-type="bibr" rid="b51-jcp-23-117">51</xref> Significantly high concentrations of butyrate and propionate in obese children compared with normal-weight children were also reported.<xref ref-type="bibr" rid="b52-jcp-23-117">52</xref></p>
<p>A classic animal study using DMH colon cancer model showed that sodium butyrate treatment enhanced the development of colon neoplasm, while having increased fecal butyric acid concentration.<xref ref-type="bibr" rid="b45-jcp-23-117">45</xref> To seperate the effect of sodium, tributyrin was administered to AOM mouse model. Although tributyrin feeding resulted in 10-fold increase in butyric acid in feces, AOM induced dysplasia or colon tumor showed no difference between the tributyrin fed and control mice.<xref ref-type="bibr" rid="b46-jcp-23-117">46</xref> Recently, direct instillation of sodium butyrate to represent the concentration of the SCFA in the distal part of the colon resulted in aberrant proliferation and transformation of colon epithelial cells in APC<sup>Min/+</sup>MutS Homolog 2<sup>−−</sup> mice.<xref ref-type="bibr" rid="b50-jcp-23-117">50</xref></p>
<p>This discrepancy regarding the effect of butyrate on colon neoplasm could partly be attributed to the fiber itself that could play as a confounder.<xref ref-type="bibr" rid="b53-jcp-23-117">53</xref> Many studies testing the effect of butyrate on colon cancer development used dietary fiber as their source for butyrate production. However, the fiber may have independent effects from that of butyrate.<xref ref-type="bibr" rid="b53-jcp-23-117">53</xref> Dietary fiber can dilute possible carcinogens by increasing fecal bulk.<xref ref-type="bibr" rid="b54-jcp-23-117">54</xref> It also shortens time for proteolytic fermentation which may result in tumorigenic metabolites. Fiber could also bind carcinogens such as secondary bile acids.<xref ref-type="bibr" rid="b54-jcp-23-117">54</xref> Furthermore, many fibers contain health-promoting substances such as phytate and phytosterols.<xref ref-type="bibr" rid="b53-jcp-23-117">53</xref> In addition, the difference between in vitro vs. in vivo vs. human study can be another important factor explaining the discrepancy in the results.<xref ref-type="bibr" rid="b53-jcp-23-117">53</xref></p>
<p>Recently, a probiotic clinical trial proposed a ‘rebalancing’ of butyrate concentration by administrating <italic>Lactobacillus paracasei</italic> DG.<xref ref-type="bibr" rid="b55-jcp-23-117">55</xref> Interestingly, they found that the effect of the probiotic on the microbiota and SFCAs was associated with initial fecal butyrate concentration.<xref ref-type="bibr" rid="b55-jcp-23-117">55</xref> Specifically, objects with inital butyrate higher than 100 mmol/kg of wet feces showed reduction in butyrate and decrease in Colostridales genera. In contrast, for those with initial butyrate lower than 25 mmol/kg, the probiotic treatment increased butyrate concentration and decreased <italic>Ruminococcus</italic>. based on these results, they suggested that fecal butyrate concentration may represent a biomarker to classify the subjects who might benefit from the probiotic treatment.<xref ref-type="bibr" rid="b55-jcp-23-117">55</xref></p>
</sec>
</sec>
<sec>
<title>2. β-glucuronidase</title>
<p>Kim and Jin<xref ref-type="bibr" rid="b56-jcp-23-117">56</xref> investigated the relationship between intestinal bacterial β-glucuronidase and colon cancer. After sonication of fecal specimens, the β-glucuronidase activity of colon cancer patients was 12.1 times higher than that of the controls.<xref ref-type="bibr" rid="b56-jcp-23-117">56</xref> Animal study was also performed to elucidate the inducing factor for β-glucuronidase by injecting DMH and benzo[a]pyrene to rats. The bile from DMH- and benzo[a]pyrene-treated rats induced β-glucuronidase in <italic>E. coli</italic> HGU-3, a β-glucuronidase producing bacterium from human intestine.<xref ref-type="bibr" rid="b56-jcp-23-117">56</xref> The result implied the role of bacteria in converting the pro-carcinogens to carcinogen in the gut.<xref ref-type="bibr" rid="b57-jcp-23-117">57</xref>,<xref ref-type="bibr" rid="b58-jcp-23-117">58</xref></p>
</sec>
<sec>
<title>3. Nitroso compunds</title>
<p>N-nitroso compounds (NOC) are known to exert highly carcinogenic effects following the formation of potent DNA alkylating agents during metabolism. The apparent total N-nitroso compound (ATNC) in food is generally non-detectable, the measurable fecal concentration of ATNC is suggested to be produced endogenously by N-nitrosation.<xref ref-type="bibr" rid="b59-jcp-23-117">59</xref>,<xref ref-type="bibr" rid="b60-jcp-23-117">60</xref> Although most dietary nitrate and nitrite are absorbed in upper gastrointestinal tract and excreted in the urine, people consuming a large amount of red meat can have nitrosating agents through colon.<xref ref-type="bibr" rid="b61-jcp-23-117">61</xref></p>
<p>Nitrate present in food and water is reduced by gut bacterial nitrate reductase to nitrite. Then nitrite reacts with nitrogenous compounds to produce NOC.<xref ref-type="bibr" rid="b12-jcp-23-117">12</xref>,<xref ref-type="bibr" rid="b60-jcp-23-117">60</xref> Laboratory studies have shown that the bacterial strains belonging to <italic>Escherichia, Pseudomonas, Proteus, Klebsiella,</italic> and <italic>Neissera</italic> families nitrosate the nitrogenous precursors.<xref ref-type="bibr" rid="b60-jcp-23-117">60</xref>,<xref ref-type="bibr" rid="b61-jcp-23-117">61</xref> And the nitrate and nitrite reductase genes regulate the N-nitrosation activity.<xref ref-type="bibr" rid="b60-jcp-23-117">60</xref> Most of these microbiota belong to facultative anaerobes that can also use nitrate or nitrite for respiratory denitrification by reducing nitrate to nitrite, NO, N<sub>2</sub>O and N<sub>2</sub>.<xref ref-type="bibr" rid="b61-jcp-23-117">61</xref> ATNC investigated in germ-free and conventional microflora rats supports this concept, showing the ATNC in the stomach and large intestine of the conventional animals were formed by microbial action.<xref ref-type="bibr" rid="b62-jcp-23-117">62</xref></p>
</sec>
<sec>
<title>4. Heme</title>
<p>Heme iron is more abundant in red meat than white meat and fish, and they mediate transportation of nitrosating agents.<xref ref-type="bibr" rid="b61-jcp-23-117">61</xref> Dietary heme was also reported to alter the microflora by decreasing the number of Gram-positive bacteria, leading to expansion of Gram-negative community.<xref ref-type="bibr" rid="b63-jcp-23-117">63</xref>,<xref ref-type="bibr" rid="b64-jcp-23-117">64</xref> An animal study reported that mice fed with a diet supplemented with heme showed a damaged gut epithelium and hyperproliferation.<xref ref-type="bibr" rid="b65-jcp-23-117">65</xref> The damage and hyperproliferation was not observed in mice that received heme and antibiotics together, implying the role of microbiota in heme-induced epithelial hyperplasia.<xref ref-type="bibr" rid="b65-jcp-23-117">65</xref> In the study, antibiotics were shown to block heme-induced differential expression of oncogenes, tumor suppressors, and cell turnover genes, implying that antibiotic treatment prevented the heme- dependent cytotoxicity to the epithelium. The protective effect of antibiotics was attributed to elimination of sulfide-producing bacteria and mucin-degrading bacteria such as <italic>Akkermansia</italic>, because sulfide reduces disulfide bond to cause mucin denaturation.<xref ref-type="bibr" rid="b65-jcp-23-117">65</xref></p>
<p>A recent study also reported that dietary heme induces gut dysbiosis such as a decrease in α-diversity, a reduction of <italic>Firmicutes</italic> and an increase of <italic>Proteobacteria</italic>, particularly <italic>Enterobacteriaceae</italic>.<xref ref-type="bibr" rid="b66-jcp-23-117">66</xref> The change was similar to dextran sodium sulfate-induced colitis model. A reduction in fecal butyrate levels was also found in mice fed the heme supplemented diet, compared to the control mice.<xref ref-type="bibr" rid="b66-jcp-23-117">66</xref> Mice with heme-supplemented diet also showed higher number of large adenomatous polyps than the those with control diet.<xref ref-type="bibr" rid="b66-jcp-23-117">66</xref></p>
</sec>
<sec>
<title>5. Secondary bile acids</title>
<p>Diet rapidly alters the gut microbiome.<xref ref-type="bibr" rid="b67-jcp-23-117">67</xref> As bile acids are involved in the absorption of dietary fat in the intestine,<xref ref-type="bibr" rid="b68-jcp-23-117">68</xref> high-fat diets (HFDs) induce an increase in bile secretion. Liver secretes cholic and chenodeoxycholic acids. Secondary bile acids are the metabolites produced by intestinal bacteria from primary bile acids. Large bowel anaerobic bacteria deconjugates and dehydroxylates, cleaving glycine and taurine residues to form the secondary bile acids such as deoxycholic acid and lithocholic acid.<xref ref-type="bibr" rid="b29-jcp-23-117">29</xref>,<xref ref-type="bibr" rid="b60-jcp-23-117">60</xref> Metagenomic analysis showed that the microbial bile salt hydrolase activity is identified in all major bacterial divisions in the gut.<xref ref-type="bibr" rid="b69-jcp-23-117">69</xref> Bile salt hydrolase confer bile tolerance and hence improvement in survival of bacteria in murine intestine.<xref ref-type="bibr" rid="b69-jcp-23-117">69</xref> However, to the host, continuous exposure to the certain hydrophobic bile acids may induce oxidative DNA damage that might lead to tumorigenesis.<xref ref-type="bibr" rid="b68-jcp-23-117">68</xref> In serum and bile of patients with colonic adenomas, more deoxycholic acid was detected than in healthy controls.<xref ref-type="bibr" rid="b70-jcp-23-117">70</xref> Secondary bile acids are toxic to several cell systems at physiological concentrations.<xref ref-type="bibr" rid="b70-jcp-23-117">70</xref> Direct installation of secondary bile acids in the large bowel can be tumor promoting. Infusion of deoxycholic acid led to damage of the mucosa, provoking increased cell proliferation.<xref ref-type="bibr" rid="b71-jcp-23-117">71</xref> Deoxycholic acid has been reported to cause resistance to apoptosis, as suggested from tissue specimens<xref ref-type="bibr" rid="b72-jcp-23-117">72</xref> and cell-line studies.<xref ref-type="bibr" rid="b73-jcp-23-117">73</xref> Microbial genes encoding for secondary bile acid production were more abundant in African Americans with high risk of colon cancer, whereas those encoding for methanogenesis and hydrogen sulfide production were higher in rural native Africans with low risk of the disease.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref> Fecal secondary bile acid concentrations were higher in African Americans, whereas SFCAs were higher in native Africans.<xref ref-type="bibr" rid="b30-jcp-23-117">30</xref></p>
</sec>
</sec>
<sec>
<title>FUNGI</title>
<p>Yeast constitutes &lt; 0.1% of microbiota. Most yeast isolates from the gastrointestinal tract are <italic>Candida albicans</italic>, and <italic>Torulopsis glabratra</italic> and <italic>C. tropicalis</italic> are occasionally discovered.<xref ref-type="bibr" rid="b74-jcp-23-117">74</xref> Saccharomyces boulardii, one strain of yeast, has been used as a probiotic for the treatment and prevention of diarrhea.<xref ref-type="bibr" rid="b74-jcp-23-117">74</xref> In recent study investigating human colonic mucosa, they reported an increase in biodiversity of fungal microbiota in sporadic cancer patients.<xref ref-type="bibr" rid="b14-jcp-23-117">14</xref> They also found a trend of increased proportion of Basidiomycota in colitis-associated cancer mucosa, implying a local dysbiosis.<xref ref-type="bibr" rid="b14-jcp-23-117">14</xref></p>
</sec>
<sec>
<title>AGE, GENDER AND MICROBIOTA</title>
<p>Microbiota undergoes changes according to age.<xref ref-type="bibr" rid="b75-jcp-23-117">75</xref> A pyrosequencing study of fecal microbiota showed that the core microbiota of elderly subjects is different from that of younger adults, having a greater proportion of <italic>Bacteroides</italic> species and distinct abundance patterns of <italic>Clostridium</italic> groups.<xref ref-type="bibr" rid="b75-jcp-23-117">75</xref> In centenarians, the microbiota is characterized by a rearrangement in the <italic>Firmicutes</italic> population and enrichment in facultative anaerobes such as pathobionts.<xref ref-type="bibr" rid="b76-jcp-23-117">76</xref> The age-related change directs the elderly intestines to be in a high proinflammatory status through chronic age-related stimulation of macrophage.<xref ref-type="bibr" rid="b76-jcp-23-117">76</xref>,<xref ref-type="bibr" rid="b77-jcp-23-117">77</xref> A recent study reported the regional difference of gut bacteria in old age rats.<xref ref-type="bibr" rid="b78-jcp-23-117">78</xref> The old rats showed the higher abundance of <italic>Ruminococcaceae</italic> and <italic>Lachnospiraceae</italic>, which breakdown polysaccharides to produce butyrate.<xref ref-type="bibr" rid="b78-jcp-23-117">78</xref> Notably, <italic>Deltaproteobacteria</italic>, a sulfate-reducing bacteria to produce genotoxic H<sub>2</sub>S, was significantly increased with aging in rat cecum.<xref ref-type="bibr" rid="b78-jcp-23-117">78</xref> Recently we published the article regarding microbial changes and host response in F344 rat colon depending on sex and age following an HFD which suggests a link between HFD-induced gut dysbiosis (particularly the low species richness and high abundance ratios of <italic>Desulfovibrio</italic> spp. and <italic>C. lavalense</italic>) and cell proliferation of colon mucosa (indicated by Ki67 IHC).<xref ref-type="bibr" rid="b79-jcp-23-117">79</xref> In addition, sex difference influenced the response of gut microbiome to HFD particularly in old age, and it might be linked to the differences of inflammation in the colon mucosa according to gender.<xref ref-type="bibr" rid="b79-jcp-23-117">79</xref></p>
</sec>
<sec sec-type="conclusions">
<title>CONCLUSION</title>
<p>The role of microbiota is a hot topic not only in the gastroenterological area including inflammatory bowel disease, irritable bowel disease and colon cancer but also in the depression and autism. Recently there has been a big progress in the studies on metabolic properties of microbiota such as butyrate production, facilitation of heme toxicity, bile acid transformation, and nitrate reduction which contribute to colon carcinogenesis. In this review article we tried to summarize the comprehensive information regarding microbiota and colon cancer including recent scientific evidence. Further research on this subject could suggest noble preventive measures for the disease.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the government of the Republic of Korea (2016R1A2B4013133).</p>
<p>And we thank prof. Hyuk Yoon for giving us valuable comments to improve this review article.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement" id="fn1-jcp-23-117">
<p>
<bold>CONFLICTS OF INTEREST</bold>
</p>
<p>No potential conflicts of interest were disclosed.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-jcp-23-117">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Dikshit</surname><given-names>R</given-names></name><name><surname>Eser</surname><given-names>S</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Rebelo</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title>. <source/>Int J Cancer
<year>2015</year>; <volume>136</volume>:<fpage>E359</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1002/ijc.29210</pub-id><pub-id pub-id-type="pmid">25220842</pub-id></mixed-citation>
</ref>
<ref id="b2-jcp-23-117">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>V</given-names></name><name><surname>Victorino</surname><given-names>AP</given-names></name><name><surname>Thuler</surname><given-names>LC</given-names></name><name><surname>Ferreira</surname><given-names>CG</given-names></name></person-group>
<article-title>Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality</article-title>. <source/>Clin Colorectal Cancer
<year>2016</year>;<volume>15</volume>:<fpage>195</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="doi">10.1016/j.clcc.2016.02.008</pub-id><pub-id pub-id-type="pmid">26964802</pub-id></mixed-citation>
</ref>
<ref id="b3-jcp-23-117">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thursby</surname><given-names>E</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name></person-group>
<article-title>Introduction to the human gut microbiota</article-title>. <source/>Biochem J
<year>2017</year>;<volume>474</volume>:<fpage>1823</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1042/BCJ20160510</pub-id><!--<pub-id pub-id-type="pmcid">5433529</pub-id>--><pub-id pub-id-type="pmid">28512250</pub-id></mixed-citation>
</ref>
<ref id="b4-jcp-23-117">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name><name><surname>Macpherson</surname><given-names>AJ</given-names></name></person-group>
<article-title>Interactions between the microbiota and the immune system</article-title>. <source/>Science
<year>2012</year>;<volume>336</volume>: <fpage>1268</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1126/science.1223490</pub-id><!--<pub-id pub-id-type="pmcid">4420145</pub-id>--><pub-id pub-id-type="pmid">22674334</pub-id></mixed-citation>
</ref>
<ref id="b5-jcp-23-117">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>DeBoy</surname><given-names>RT</given-names></name><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Samuel</surname><given-names>BS</given-names></name><etal></etal></person-group>
<article-title>Metagenomic analysis of the human distal gut microbiome</article-title>. <source/>Science
<year>2006</year>;<volume>312</volume>:<fpage>1355</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.1124234</pub-id><!--<pub-id pub-id-type="pmcid">3027896</pub-id>--><pub-id pub-id-type="pmid">16741115</pub-id></mixed-citation>
</ref>
<ref id="b6-jcp-23-117">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sender</surname><given-names>R</given-names></name><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Milo</surname><given-names>R</given-names></name></person-group>
<article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source/>PLoS Biol
<year>2016</year>;<volume>14</volume>: <fpage>e1002533</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id><!--<pub-id pub-id-type="pmcid">4991899</pub-id>--><pub-id pub-id-type="pmid">27541692</pub-id></mixed-citation>
</ref>
<ref id="b7-jcp-23-117">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egert</surname><given-names>M</given-names></name><name><surname>De Graaf</surname><given-names>AA</given-names></name><name><surname>Smidt</surname><given-names>H</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Venema</surname><given-names>K</given-names></name></person-group>
<article-title>Beyond diversity: functional microbiomics of the human colon</article-title>. <source/>Trends Microbiol
<year>2006</year>;<volume>14</volume>:<fpage>86</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.tim.2005.12.007</pub-id><pub-id pub-id-type="pmid">16406528</pub-id></mixed-citation>
</ref>
<ref id="b8-jcp-23-117">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Possemiers</surname><given-names>S</given-names></name><name><surname>Bolca</surname><given-names>S</given-names></name><name><surname>Verstraete</surname><given-names>W</given-names></name><name><surname>Heyerick</surname><given-names>A</given-names></name></person-group>
<article-title>The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals</article-title>. <source/>Fitoterapia
<year>2011</year>;<volume>82</volume>:<fpage>53</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.fitote.2010.07.012</pub-id><pub-id pub-id-type="pmid">20655994</pub-id></mixed-citation>
</ref>
<ref id="b9-jcp-23-117">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulal</surname><given-names>S</given-names></name><name><surname>Keku</surname><given-names>TO</given-names></name></person-group>
<article-title>Gut microbiome and colorectal adenomas</article-title>. <source/>Cancer J
<year>2014</year>;<volume>20</volume>:<fpage>225</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1097/PPO.0000000000000050</pub-id><!--<pub-id pub-id-type="pmcid">4589167</pub-id>--><pub-id pub-id-type="pmid">24855012</pub-id></mixed-citation>
</ref>
<ref id="b10-jcp-23-117">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group>
<article-title>A genetic model for colorectal tumorigenesis</article-title>. <source/>Cell
<year>1990</year>;<volume>61</volume>:<fpage>759</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/0092-8674(90)90186-I</pub-id><pub-id pub-id-type="pmid">2188735</pub-id></mixed-citation>
</ref>
<ref id="b11-jcp-23-117">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Thaiss</surname><given-names>CA</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name></person-group>
<article-title>The microbiota: a new player in the etiology of colorectal cancer</article-title>. <source/>Curr Colorectal Cancer Rep
<year>2014</year>; <volume>10</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/s11888-013-0196-z</pub-id></mixed-citation>
</ref>
<ref id="b12-jcp-23-117">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>IR</given-names></name></person-group>
<article-title>The role of the gastrointestinal microbiota in colorectal cancer</article-title>. <source/>Curr Pharm Des
<year>2009</year>;<volume>15</volume>:<fpage>1524</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2174/138161209788168191</pub-id><pub-id pub-id-type="pmid">19442169</pub-id></mixed-citation>
</ref>
<ref id="b13-jcp-23-117">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Dutilh</surname><given-names>BE</given-names></name><name><surname>Hall</surname><given-names>N</given-names></name><name><surname>Peters</surname><given-names>WH</given-names></name><name><surname>Roelofs</surname><given-names>R</given-names></name><name><surname>Boleij</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Towards the human colorectal cancer microbiome</article-title>. <source/>PLoS One
<year>2011</year>;<volume>6</volume>:<fpage>e20447</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0020447</pub-id><!--<pub-id pub-id-type="pmcid">3101260</pub-id>--><pub-id pub-id-type="pmid">21647227</pub-id></mixed-citation>
</ref>
<ref id="b14-jcp-23-117">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>ML</given-names></name><name><surname>Liguori</surname><given-names>G</given-names></name><name><surname>Lamas</surname><given-names>B</given-names></name><name><surname>Brandi</surname><given-names>G</given-names></name><name><surname>da Costa</surname><given-names>G</given-names></name><name><surname>Hoffmann</surname><given-names>TW</given-names></name><etal></etal></person-group>
<article-title>Mucosa-associated microbiota dysbiosis in colitis associated cancer</article-title>. <source/>Gut Microbes
<year>2018</year>;<volume>4</volume>:<fpage>131</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1080/19490976.2017.1379637</pub-id></mixed-citation>
</ref>
<ref id="b15-jcp-23-117">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Kato</surname><given-names>I</given-names></name></person-group>
<article-title>Gut microbiota, inflammation and colorectal cancer</article-title>. <source/>Genes Dis
<year>2016</year>;<volume>3</volume>:<fpage>130</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.gendis.2016.03.004</pub-id><pub-id pub-id-type="pmid">28078319</pub-id></mixed-citation>
</ref>
<ref id="b16-jcp-23-117">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>ME</given-names></name><name><surname>Phillipson</surname><given-names>M</given-names></name><name><surname>Petersson</surname><given-names>J</given-names></name><name><surname>Velcich</surname><given-names>A</given-names></name><name><surname>Holm</surname><given-names>L</given-names></name><name><surname>Hansson</surname><given-names>GC</given-names></name></person-group>
<article-title>The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2008</year>;<volume>105</volume>:<fpage>15064</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0803124105</pub-id><!--<pub-id pub-id-type="pmcid">2567493</pub-id>--><pub-id pub-id-type="pmid">18806221</pub-id></mixed-citation>
</ref>
<ref id="b17-jcp-23-117">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelsall</surname><given-names>B</given-names></name></person-group>
<article-title>Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages</article-title>. <source/>Mucosal Immunol
<year>2008</year>;<volume>1</volume>:<fpage>460</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2008.61</pub-id><!--<pub-id pub-id-type="pmcid">4780321</pub-id>--><pub-id pub-id-type="pmid">19079213</pub-id></mixed-citation>
</ref>
<ref id="b18-jcp-23-117">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlaskalová-Hogenová</surname><given-names>H</given-names></name><name><surname>Stepánková</surname><given-names>R</given-names></name><name><surname>Hudcovic</surname><given-names>T</given-names></name><name><surname>Tucková</surname><given-names>L</given-names></name><name><surname>Cukrowska</surname><given-names>B</given-names></name><name><surname>Lodinová-Zádníková</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases</article-title>. <source/>Immunol Lett
<year>2004</year>;<volume>93</volume>:<fpage>97</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="doi">10.1016/j.imlet.2004.02.005</pub-id><pub-id pub-id-type="pmid">15158604</pub-id></mixed-citation>
</ref>
<ref id="b19-jcp-23-117">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucci</surname><given-names>L</given-names></name><name><surname>Stepankova</surname><given-names>R</given-names></name><name><surname>Kozakova</surname><given-names>H</given-names></name><name><surname>Fiserova</surname><given-names>A</given-names></name><name><surname>Rossmann</surname><given-names>P</given-names></name><name><surname>Tlaskalova-Hogenova</surname><given-names>H</given-names></name></person-group>
<article-title>Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity</article-title>. <source/>Int J Oncol
<year>2008</year>;<volume>32</volume>:<fpage>609</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">18292938</pub-id></mixed-citation>
</ref>
<ref id="b20-jcp-23-117">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Hemmi</surname><given-names>H</given-names></name></person-group>
<article-title>Recognition of pathogen-associated molecular patterns by TLR family</article-title>. <source/>Immunol Lett
<year>2003</year>;<volume>85</volume>:<fpage>85</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-2478(02)00228-6</pub-id><pub-id pub-id-type="pmid">12527213</pub-id></mixed-citation>
</ref>
<ref id="b21-jcp-23-117">
<label>21</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bland</surname><given-names>PW</given-names></name></person-group>
<source/>Mucosal T cell-epithelial cell interactions, mucosal T cells. <publisher-loc>New York</publisher-loc>, <publisher-name>Karger Publishers</publisher-name>, <year>1998</year>:<fpage>40</fpage>–<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="b22-jcp-23-117">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>GP</given-names></name><name><surname>Ladinsky</surname><given-names>MS</given-names></name><name><surname>Yu</surname><given-names>KB</given-names></name><name><surname>Sanders</surname><given-names>JG</given-names></name><name><surname>Yoo</surname><given-names>BB</given-names></name><name><surname>Chou</surname><given-names>WC</given-names></name><etal></etal></person-group>
<article-title>Gut microbiota utilize immunoglobulin A for mucosal colonization</article-title>. <source/>Science
<year>2018</year>;<volume>360</volume>:<fpage>795</fpage>–<lpage>800</lpage>.<pub-id pub-id-type="doi">10.1126/science.aaq0926</pub-id><!--<pub-id pub-id-type="pmcid">5973787</pub-id>--><pub-id pub-id-type="pmid">29724905</pub-id></mixed-citation>
</ref>
<ref id="b23-jcp-23-117">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cebra</surname><given-names>JJ</given-names></name></person-group>
<article-title>Influences of microbiota on intestinal immune system development</article-title>. <source/>Am J Clin Nutr
<year>1999</year>;<volume>69</volume>:<fpage>1046s</fpage>–<lpage>51s</lpage>.<pub-id pub-id-type="doi">10.1093/ajcn/69.5.1046s</pub-id><pub-id pub-id-type="pmid">10232647</pub-id></mixed-citation>
</ref>
<ref id="b24-jcp-23-117">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>BS</given-names></name><name><surname>Narisawa</surname><given-names>T</given-names></name><name><surname>Maronpot</surname><given-names>R</given-names></name><name><surname>Weisburger</surname><given-names>JH</given-names></name><name><surname>Wynder</surname><given-names>EL</given-names></name></person-group>
<article-title>Animal models for the study of dietary factors and cancer of the large bowel</article-title>. <source/>Cancer Res
<year>1975</year>;<volume>35</volume>:<fpage>3421</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">1192409</pub-id></mixed-citation>
</ref>
<ref id="b25-jcp-23-117">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funabashi</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Kado</surname><given-names>S</given-names></name><name><surname>Matsuoka</surname><given-names>Y</given-names></name><name><surname>Ohwaki</surname><given-names>M</given-names></name></person-group>
<article-title>Establishment of a Tcrb and Trp53 genes deficient mouse strain as an animal model for spontaneous colorectal cancer</article-title>. <source/>Exp Anim
<year>2001</year>;<volume>50</volume>:<fpage>41</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1538/expanim.50.41</pub-id><pub-id pub-id-type="pmid">11326422</pub-id></mixed-citation>
</ref>
<ref id="b26-jcp-23-117">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kado</surname><given-names>S</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Funabashi</surname><given-names>H</given-names></name><name><surname>Iwata</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>Y</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice</article-title>. <source/>Cancer Res
<year>2001</year>;<volume>61</volume>:<fpage>2395</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">11289103</pub-id></mixed-citation>
</ref>
<ref id="b27-jcp-23-117">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dove</surname><given-names>WF</given-names></name><name><surname>Clipson</surname><given-names>L</given-names></name><name><surname>Gould</surname><given-names>KA</given-names></name><name><surname>Luongo</surname><given-names>C</given-names></name><name><surname>Marshall</surname><given-names>DJ</given-names></name><name><surname>Moser</surname><given-names>AR</given-names></name><etal></etal></person-group>
<article-title>Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status</article-title>. <source/>Cancer Res
<year>1997</year>;<volume>57</volume>:<fpage>812</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">9041176</pub-id></mixed-citation>
</ref>
<ref id="b28-jcp-23-117">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomkovich</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Winglee</surname><given-names>K</given-names></name><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Mühlbauer</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><etal></etal></person-group>
<article-title>Locoregional effects of microbiota in a preclinical model of colon carcinogenesis</article-title>. <source/>Cancer Res
<year>2017</year>;<volume>77</volume>:<fpage>2620</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-3472</pub-id><!--<pub-id pub-id-type="pmcid">5468752</pub-id>--><pub-id pub-id-type="pmid">28416491</pub-id></mixed-citation>
</ref>
<ref id="b29-jcp-23-117">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louis</surname><given-names>P</given-names></name><name><surname>Hold</surname><given-names>GL</given-names></name><name><surname>Flint</surname><given-names>HJ</given-names></name></person-group>
<article-title>The gut microbiota, bacterial metabolites and colorectal cancer</article-title>. <source/>Nat Rev Microbiol
<year>2014</year>;<volume>12</volume>:<fpage>661</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro3344</pub-id><pub-id pub-id-type="pmid">25198138</pub-id></mixed-citation>
</ref>
<ref id="b30-jcp-23-117">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Carbonero</surname><given-names>F</given-names></name><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>DeLany</surname><given-names>JP</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Newton</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans</article-title>. <source/>Am J Clin Nutr
<year>2013</year>;<volume>98</volume>:<fpage>111</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.3945/ajcn.112.056689</pub-id><!--<pub-id pub-id-type="pmcid">3683814</pub-id>--><pub-id pub-id-type="pmid">23719549</pub-id></mixed-citation>
</ref>
<ref id="b31-jcp-23-117">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownawell</surname><given-names>AM</given-names></name><name><surname>Caers</surname><given-names>W</given-names></name><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>Kendall</surname><given-names>CW</given-names></name><name><surname>Lewis</surname><given-names>KD</given-names></name><name><surname>Ringel</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals</article-title>. <source/>J Nutr
<year>2012</year>; <volume>142</volume>:<fpage>962</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.3945/jn.112.158147</pub-id><pub-id pub-id-type="pmid">22457389</pub-id></mixed-citation>
</ref>
<ref id="b32-jcp-23-117">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivière</surname><given-names>A</given-names></name><name><surname>Selak</surname><given-names>M</given-names></name><name><surname>Lantin</surname><given-names>D</given-names></name><name><surname>Leroy</surname><given-names>F</given-names></name><name><surname>De Vuyst</surname><given-names>L</given-names></name></person-group>
<article-title>Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut</article-title>. <source/>Front Microbiol
<year>2016</year>; <volume>7</volume>:<fpage>979</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2016.00979</pub-id><!--<pub-id pub-id-type="pmcid">4923077</pub-id>--><pub-id pub-id-type="pmid">27446020</pub-id></mixed-citation>
</ref>
<ref id="b33-jcp-23-117">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Encarnação</surname><given-names>J</given-names></name><name><surname>Abrantes</surname><given-names>AM</given-names></name><name><surname>Pires</surname><given-names>AS</given-names></name><name><surname>Botelho</surname><given-names>MF</given-names></name></person-group>
<article-title>Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment</article-title>. <source/>Cancer Metastasis Rev
<year>2015</year>;<volume>34</volume>:<fpage>465</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1007/s10555-015-9578-9</pub-id><pub-id pub-id-type="pmid">26224132</pub-id></mixed-citation>
</ref>
<ref id="b34-jcp-23-117">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Vitetta</surname><given-names>L</given-names></name></person-group>
<article-title>Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber</article-title>. <source/>Clin Colorectal Cancer
<year>2018</year>;<volume>17</volume>:<fpage>e541</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.clcc.2018.05.001</pub-id><pub-id pub-id-type="pmid">29866614</pub-id></mixed-citation>
</ref>
<ref id="b35-jcp-23-117">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>DR</given-names></name><name><surname>Collins</surname><given-names>LB</given-names></name><name><surname>Wali</surname><given-names>A</given-names></name><name><surname>Bigler</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Bultman</surname><given-names>SJ</given-names></name></person-group>
<article-title>The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation</article-title>. <source/>Mol Cell
<year>2012</year>;<volume>48</volume>: <fpage>612</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.molcel.2012.08.033</pub-id><!--<pub-id pub-id-type="pmcid">3513569</pub-id>--><pub-id pub-id-type="pmid">23063526</pub-id></mixed-citation>
</ref>
<ref id="b36-jcp-23-117">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group>
<article-title>Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer</article-title>. <source/>J Cancer
<year>2018</year>;<volume>9</volume>:<fpage>2510</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.7150/jca.25324</pub-id><!--<pub-id pub-id-type="pmcid">6036887</pub-id>--><pub-id pub-id-type="pmid">30026849</pub-id></mixed-citation>
</ref>
<ref id="b37-jcp-23-117">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphreys</surname><given-names>KJ</given-names></name><name><surname>Conlon</surname><given-names>MA</given-names></name><name><surname>Young</surname><given-names>GP</given-names></name><name><surname>Topping</surname><given-names>DL</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Winter</surname><given-names>JM</given-names></name><etal></etal></person-group>
<article-title>Dietary manipulation of oncogenic microRNA expression in human rectal mucosa: a randomized trial</article-title>. <source/>Cancer Prev Res (Phila)
<year>2014</year>;<volume>7</volume>:<fpage>786</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-14-0053</pub-id><pub-id pub-id-type="pmid">25092886</pub-id></mixed-citation>
</ref>
<ref id="b38-jcp-23-117">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furusawa</surname><given-names>Y</given-names></name><name><surname>Obata</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Endo</surname><given-names>TA</given-names></name><name><surname>Nakato</surname><given-names>G</given-names></name><name><surname>Takahashi</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source/>Nature
<year>2013</year>;<volume>504</volume>:<fpage>446</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/nature12721</pub-id><pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation>
</ref>
<ref id="b39-jcp-23-117">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>MA</given-names></name><name><surname>Bird</surname><given-names>AR</given-names></name><name><surname>Clarke</surname><given-names>JM</given-names></name><name><surname>Le Leu</surname><given-names>RK</given-names></name><name><surname>Christophersen</surname><given-names>CT</given-names></name><name><surname>Lockett</surname><given-names>TJ</given-names></name><etal></etal></person-group>
<article-title>Lowering of large bowel butyrate levels in healthy populations is unlikely to be beneficial</article-title>. <source/>J Nutri
<year>2015</year>;<volume>145</volume>:<fpage>1030</fpage>–<lpage>1</lpage>.<pub-id pub-id-type="doi">10.3945/jn.114.209460</pub-id></mixed-citation>
</ref>
<ref id="b40-jcp-23-117">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Gurav</surname><given-names>A</given-names></name><name><surname>Sivaprakasam</surname><given-names>S</given-names></name><name><surname>Brady</surname><given-names>E</given-names></name><name><surname>Padia</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis</article-title>. <source/>Immunity
<year>2014</year>;<volume>40</volume>:<fpage>128</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.007</pub-id><!--<pub-id pub-id-type="pmcid">4305274</pub-id>--><pub-id pub-id-type="pmid">24412617</pub-id></mixed-citation>
</ref>
<ref id="b41-jcp-23-117">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Abbeele</surname><given-names>P</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Goossens</surname><given-names>M</given-names></name><name><surname>Kleerebezem</surname><given-names>M</given-names></name><name><surname>De Vos</surname><given-names>WM</given-names></name><name><surname>Thas</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model</article-title>. <source/>ISME J
<year>2013</year>;<volume>7</volume>:<fpage>949</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1038/ismej.2012.158</pub-id><!--<pub-id pub-id-type="pmcid">3635240</pub-id>--><pub-id pub-id-type="pmid">23235287</pub-id></mixed-citation>
</ref>
<ref id="b42-jcp-23-117">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasquez-Manoff</surname><given-names>M</given-names></name></person-group>
<article-title>Gut microbiome: the peacekeepers</article-title>. <source/>Nature
<year>2015</year>;<volume>518</volume>:<fpage>S3</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1038/518S3a</pub-id><pub-id pub-id-type="pmid">25715278</pub-id></mixed-citation>
</ref>
<ref id="b43-jcp-23-117">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Dysbiosis signature of fecal microbiota in colorectal cancer patients</article-title>. <source/>Microb Ecol
<year>2013</year>;<volume>66</volume>:<fpage>462</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1007/s00248-013-0245-9</pub-id><pub-id pub-id-type="pmid">23733170</pub-id></mixed-citation>
</ref>
<ref id="b44-jcp-23-117">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname><given-names>RH</given-names></name><name><surname>Young</surname><given-names>GP</given-names></name><name><surname>Bhathal</surname><given-names>PS</given-names></name></person-group>
<article-title>Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215)</article-title>. <source/>Gut
<year>1986</year>;<volume>27</volume>:<fpage>1457</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1136/gut.27.12.1457</pub-id><!--<pub-id pub-id-type="pmcid">1433981</pub-id>--><pub-id pub-id-type="pmid">3804021</pub-id></mixed-citation>
</ref>
<ref id="b45-jcp-23-117">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>HJ</given-names></name></person-group>
<article-title>Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia</article-title>. <source/>Gastroenterology
<year>1986</year>;<volume>91</volume>:<fpage>596</fpage>–<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1016/0016-5085(86)90628-1</pub-id><pub-id pub-id-type="pmid">3732764</pub-id></mixed-citation>
</ref>
<ref id="b46-jcp-23-117">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschner</surname><given-names>EE</given-names></name><name><surname>Ruperto</surname><given-names>JF</given-names></name><name><surname>Lupton</surname><given-names>JR</given-names></name><name><surname>Newmark</surname><given-names>HL</given-names></name></person-group>
<article-title>Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis</article-title>. <source/>Cancer Lett
<year>1990</year>;<volume>52</volume>:<fpage>79</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/0304-3835(90)90080-H</pub-id><pub-id pub-id-type="pmid">2354422</pub-id></mixed-citation>
</ref>
<ref id="b47-jcp-23-117">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname><given-names>SY</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name><name><surname>Shei</surname><given-names>A</given-names></name><name><surname>Hodin</surname><given-names>RA</given-names></name></person-group>
<article-title>p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells</article-title>. <source/>Proc Natl Acad Sci U S A
<year>1998</year>;<volume>95</volume>:<fpage>6791</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.95.12.6791</pub-id><!--<pub-id pub-id-type="pmcid">22637</pub-id>--><pub-id pub-id-type="pmid">9618491</pub-id></mixed-citation>
</ref>
<ref id="b48-jcp-23-117">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>SJ</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Aufreiter</surname><given-names>S</given-names></name><name><surname>O'Connor</surname><given-names>D</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Sepulveda</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Products of the colonic microbiota mediate the effects of diet on colon cancer risk</article-title>. <source/>J Nutr
<year>2009</year>;<volume>139</volume>:<fpage>2044</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.3945/jn.109.104380</pub-id><pub-id pub-id-type="pmid">19741203</pub-id></mixed-citation>
</ref>
<ref id="b49-jcp-23-117">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>DR</given-names></name><name><surname>Garge</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>O'Connell</surname><given-names>TM</given-names></name><name><surname>Bunger</surname><given-names>MK</given-names></name><etal></etal></person-group>
<article-title>The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title>. <source/>Cell Metab
<year>2011</year>;<volume>13</volume>:<fpage>517</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.cmet.2011.02.018</pub-id><!--<pub-id pub-id-type="pmcid">3099420</pub-id>--><pub-id pub-id-type="pmid">21531334</pub-id></mixed-citation>
</ref>
<ref id="b50-jcp-23-117">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belcheva</surname><given-names>A</given-names></name><name><surname>Irrazabal</surname><given-names>T</given-names></name><name><surname>Robertson</surname><given-names>SJ</given-names></name><name><surname>Streutker</surname><given-names>C</given-names></name><name><surname>Maughan</surname><given-names>H</given-names></name><name><surname>Rubino</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells</article-title>. <source/>Cell
<year>2014</year>;<volume>158</volume>:<fpage>288</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2014.04.051</pub-id><pub-id pub-id-type="pmid">25036629</pub-id></mixed-citation>
</ref>
<ref id="b51-jcp-23-117">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>TF</given-names></name><name><surname>Grześkowiak</surname><given-names>Ł</given-names></name><name><surname>Franceschini</surname><given-names>SC</given-names></name><name><surname>Bressan</surname><given-names>J</given-names></name><name><surname>Ferreira</surname><given-names>CL</given-names></name><name><surname>Peluzio</surname><given-names>MC</given-names></name></person-group>
<article-title>Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors</article-title>. <source/>Br J Nutr
<year>2013</year>;<volume>109</volume>:<fpage>914</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1017/S0007114512002723</pub-id><pub-id pub-id-type="pmid">23200109</pub-id></mixed-citation>
</ref>
<ref id="b52-jcp-23-117">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>AN</given-names></name><name><surname>Chassard</surname><given-names>C</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Stinca</surname><given-names>S</given-names></name><name><surname>Lacroix</surname><given-names>C</given-names></name></person-group>
<article-title>The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization</article-title>. <source/>Nutr Diabetes
<year>2011</year>;<volume>1</volume>:<fpage>e12</fpage>.<pub-id pub-id-type="doi">10.1038/nutd.2011.8</pub-id><!--<pub-id pub-id-type="pmcid">3302137</pub-id>--><pub-id pub-id-type="pmid">23154580</pub-id></mixed-citation>
</ref>
<ref id="b53-jcp-23-117">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupton</surname><given-names>JR</given-names></name></person-group>
<article-title>Microbial degradation products influence colon cancer risk: the butyrate controversy</article-title>. <source/>J Nutr
<year>2004</year>;<volume>134</volume>:<fpage>479</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1093/jn/134.2.479</pub-id><pub-id pub-id-type="pmid">14747692</pub-id></mixed-citation>
</ref>
<ref id="b54-jcp-23-117">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Lazarova</surname><given-names>DL</given-names></name><name><surname>Bordonaro</surname><given-names>M</given-names></name></person-group>
<article-title>Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention</article-title>. <source/>World J Gastrointest Oncol
<year>2014</year>;<volume>6</volume>:<fpage>41</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.4251/wjgo.v6.i2.41</pub-id><!--<pub-id pub-id-type="pmcid">3926973</pub-id>--><pub-id pub-id-type="pmid">24567795</pub-id></mixed-citation>
</ref>
<ref id="b55-jcp-23-117">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrario</surname><given-names>C</given-names></name><name><surname>Taverniti</surname><given-names>V</given-names></name><name><surname>Milani</surname><given-names>C</given-names></name><name><surname>Fiore</surname><given-names>W</given-names></name><name><surname>Laureati</surname><given-names>M</given-names></name><name><surname>De Noni</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults</article-title>. <source/>J Nutr
<year>2014</year>;<volume>144</volume>:<fpage>1787</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.3945/jn.114.197723</pub-id><pub-id pub-id-type="pmid">25332478</pub-id></mixed-citation>
</ref>
<ref id="b56-jcp-23-117">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Jin</surname><given-names>YH</given-names></name></person-group>
<article-title>Intestinal bacterial beta-glucuronidase activity of patients with colon cancer</article-title>. <source/>Arc Pharm Res
<year>2001</year>;<volume>24</volume>:<fpage>564</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/BF02975166</pub-id></mixed-citation>
</ref>
<ref id="b57-jcp-23-117">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liong</surname><given-names>MT</given-names></name></person-group>
<article-title>Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence</article-title>. <source/>Int J Mol Sci
<year>2008</year>;<volume>9</volume>:<fpage>854</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.3390/ijms9050854</pub-id><pub-id pub-id-type="pmid">19325789</pub-id></mixed-citation>
</ref>
<ref id="b58-jcp-23-117">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>N</given-names></name><name><surname>Reddy</surname><given-names>BS</given-names></name></person-group>
<article-title>Inhibitory effect of Bifidobacterium lon-gum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase</article-title>. <source/>Proc Soc Exp Biol Med
<year>1994</year>;<volume>207</volume>:<fpage>278</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="doi">10.3181/00379727-207-43817</pub-id><pub-id pub-id-type="pmid">7800683</pub-id></mixed-citation>
</ref>
<ref id="b59-jcp-23-117">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>I</given-names></name><name><surname>Granli</surname><given-names>T</given-names></name><name><surname>Bøckman</surname><given-names>OC</given-names></name><name><surname>Key</surname><given-names>PE</given-names></name><name><surname>Massey</surname><given-names>RC</given-names></name></person-group>
<article-title>Endogenous N-nitrosation in man assessed by measurement of apparent total N-nitroso compounds in faeces</article-title>. <source/>Carcinogenesis
<year>1991</year>;<volume>12</volume>:<fpage>1395</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1093/carcin/12.8.1395</pub-id><pub-id pub-id-type="pmid">1860160</pub-id></mixed-citation>
</ref>
<ref id="b60-jcp-23-117">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>RHIR</given-names></name></person-group>
<article-title>Metabolic activities of the gut microflora in relation to cancer</article-title>. <source/>Microb Ecol Health Dis
<year>2000</year>;<volume>12</volume>:<fpage>179</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1080/089106000750060431</pub-id></mixed-citation>
</ref>
<ref id="b61-jcp-23-117">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>J</given-names></name></person-group>
<article-title>Effect of diet and gut environment on the gastrointestinal formation of N-nitroso compounds: a review</article-title>. <source/>Nitric Oxide
<year>2018</year>;<volume>73</volume>:<fpage>66</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.niox.2017.06.001</pub-id><pub-id pub-id-type="pmid">28587887</pub-id></mixed-citation>
</ref>
<ref id="b62-jcp-23-117">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>RC</given-names></name><name><surname>Key</surname><given-names>PE</given-names></name><name><surname>Mallett</surname><given-names>AK</given-names></name><name><surname>Rowland</surname><given-names>IR</given-names></name></person-group>
<article-title>An investigation of the endogenous formation of apparent total N-nitroso compounds in conventional microflora and germ-free rats</article-title>. <source/>Food Chem Toxicol
<year>1988</year>;<volume>26</volume>:<fpage>595</fpage>–<lpage>600</lpage>.<pub-id pub-id-type="doi">10.1016/0278-6915(88)90230-X</pub-id><pub-id pub-id-type="pmid">3181835</pub-id></mixed-citation>
</ref>
<ref id="b63-jcp-23-117">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijssennagger</surname><given-names>N</given-names></name><name><surname>Derrien</surname><given-names>M</given-names></name><name><surname>van Doorn</surname><given-names>GM</given-names></name><name><surname>Rijnierse</surname><given-names>A</given-names></name><name><surname>van den Bogert</surname><given-names>B</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk</article-title>. <source/>PLoS One
<year>2012</year>;<volume>7</volume>:<fpage>e49868</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0049868</pub-id><!--<pub-id pub-id-type="pmcid">3519815</pub-id>--><pub-id pub-id-type="pmid">23239972</pub-id></mixed-citation>
</ref>
<ref id="b64-jcp-23-117">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamage</surname><given-names>SMK</given-names></name><name><surname>Dissabandara</surname><given-names>L</given-names></name><name><surname>Lam</surname><given-names>AK</given-names></name><name><surname>Gopalan</surname><given-names>V</given-names></name></person-group>
<article-title>The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma</article-title>. <source/>Crit Rev Oncol Hematol
<year>2018</year>;<volume>126</volume>:<fpage>121</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.critrevonc.2018.03.025</pub-id><pub-id pub-id-type="pmid">29759553</pub-id></mixed-citation>
</ref>
<ref id="b65-jcp-23-117">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijssennagger</surname><given-names>N</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Hooiveld</surname><given-names>GJ</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>van Mil</surname><given-names>SW</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2015</year>;<volume>112</volume>:<fpage>10038</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1507645112</pub-id><!--<pub-id pub-id-type="pmcid">4538683</pub-id>--><pub-id pub-id-type="pmid">26216954</pub-id></mixed-citation>
</ref>
<ref id="b66-jcp-23-117">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constante</surname><given-names>M</given-names></name><name><surname>Fragoso</surname><given-names>G</given-names></name><name><surname>Calvé</surname><given-names>A</given-names></name><name><surname>Samba-Mondonga</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>MM</given-names></name></person-group>
<article-title>Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice</article-title>. <source/>Front Microbiol
<year>2017</year>;<volume>8</volume>:<fpage>1809</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2017.01809</pub-id><!--<pub-id pub-id-type="pmcid">5613120</pub-id>--><pub-id pub-id-type="pmid">28983289</pub-id></mixed-citation>
</ref>
<ref id="b67-jcp-23-117">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>LA</given-names></name><name><surname>Maurice</surname><given-names>CF</given-names></name><name><surname>Carmody</surname><given-names>RN</given-names></name><name><surname>Gootenberg</surname><given-names>DB</given-names></name><name><surname>Button</surname><given-names>JE</given-names></name><name><surname>Wolfe</surname><given-names>BE</given-names></name><etal></etal></person-group>
<article-title>Diet rapidly and reproducibly alters the human gut microbiome</article-title>. <source/>Nature
<year>2013</year>;<volume>505</volume>:<fpage>559</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1038/nature12820</pub-id><!--<pub-id pub-id-type="pmcid">3957428</pub-id>--><pub-id pub-id-type="pmid">24336217</pub-id></mixed-citation>
</ref>
<ref id="b68-jcp-23-117">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrasa</surname><given-names>JI</given-names></name><name><surname>Olmo</surname><given-names>N</given-names></name><name><surname>Lizarbe</surname><given-names>MA</given-names></name><name><surname>Turnay</surname><given-names>J</given-names></name></person-group>
<article-title>Bile acids in the colon, from healthy to cytotoxic molecules</article-title>. <source/>Toxicol In Vitro
<year>2013</year>;<volume>27</volume>:<fpage>964</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/j.tiv.2012.12.020</pub-id><pub-id pub-id-type="pmid">23274766</pub-id></mixed-citation>
</ref>
<ref id="b69-jcp-23-117">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>BV</given-names></name><name><surname>Begley</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Gahan</surname><given-names>CG</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name></person-group>
<article-title>Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2008</year>;<volume>105</volume>:<fpage>13580</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0804437105</pub-id><!--<pub-id pub-id-type="pmcid">2533232</pub-id>--><pub-id pub-id-type="pmid">18757757</pub-id></mixed-citation>
</ref>
<ref id="b70-jcp-23-117">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagengast</surname><given-names>FM</given-names></name><name><surname>Grubben</surname><given-names>MJ</given-names></name><name><surname>van Munster</surname><given-names>IP</given-names></name></person-group>
<article-title>Role of bile acids in colorectal carcinogenesis</article-title>. <source/>Eur J Cancer
<year>1995</year>;<volume>31</volume>:<fpage>1067</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/0959-8049(95)00216-6</pub-id></mixed-citation>
</ref>
<ref id="b71-jcp-23-117">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafter</surname><given-names>JJ</given-names></name><name><surname>Eng</surname><given-names>VW</given-names></name><name><surname>Furrer</surname><given-names>R</given-names></name><name><surname>Medline</surname><given-names>A</given-names></name><name><surname>Bruce</surname><given-names>WR</given-names></name></person-group>
<article-title>Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon</article-title>. <source/>Gut
<year>1986</year>;<volume>27</volume>:<fpage>1320</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/gut.27.11.1320</pub-id><!--<pub-id pub-id-type="pmcid">1434073</pub-id>--><pub-id pub-id-type="pmid">3792915</pub-id></mixed-citation>
</ref>
<ref id="b72-jcp-23-117">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>CM</given-names></name><name><surname>Bernstein</surname><given-names>H</given-names></name><name><surname>Bernstein</surname><given-names>C</given-names></name><name><surname>Garewal</surname><given-names>H</given-names></name></person-group>
<article-title>Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis</article-title>. <source/>Ultrastruct Pathol
<year>1995</year>;<volume>19</volume>:<fpage>221</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.3109/01913129509064227</pub-id><pub-id pub-id-type="pmid">7571081</pub-id></mixed-citation>
</ref>
<ref id="b73-jcp-23-117">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>AA</given-names></name><name><surname>Akare</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Herzer</surname><given-names>P</given-names></name><name><surname>Jean-Louis</surname><given-names>S</given-names></name><name><surname>Feldman</surname><given-names>RA</given-names></name><etal></etal></person-group>
<article-title>Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity</article-title>. <source/>BMC Cancer
<year>2006</year>;<volume>6</volume>:<fpage>219</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2407-6-219</pub-id><!--<pub-id pub-id-type="pmcid">1574338</pub-id>--><pub-id pub-id-type="pmid">16948850</pub-id></mixed-citation>
</ref>
<ref id="b74-jcp-23-117">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czerucka</surname><given-names>D</given-names></name><name><surname>Piche</surname><given-names>T</given-names></name><name><surname>Rampal</surname><given-names>P</given-names></name></person-group>
<article-title>Review article: yeast as probiotics --saccharomyces boulardii</article-title>. <source/>Aliment Pharmacol Ther
<year>2007</year>;<volume>26</volume>:<fpage>767</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2036.2007.03442.x</pub-id><pub-id pub-id-type="pmid">17767461</pub-id></mixed-citation>
</ref>
<ref id="b75-jcp-23-117">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claesson</surname><given-names>MJ</given-names></name><name><surname>Cusack</surname><given-names>S</given-names></name><name><surname>O'Sullivan</surname><given-names>O</given-names></name><name><surname>Greene-Diniz</surname><given-names>R</given-names></name><name><surname>de Weerd</surname><given-names>H</given-names></name><name><surname>Flannery</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Composition, variability, and temporal stability of the intestinal microbiota of the elderly</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2011</year>;<volume>108</volume>
<issue>Suppl 1</issue>:<fpage>4586</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1000097107</pub-id><!--<pub-id pub-id-type="pmcid">3063589</pub-id>--><pub-id pub-id-type="pmid">20571116</pub-id></mixed-citation>
</ref>
<ref id="b76-jcp-23-117">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biagi</surname><given-names>E</given-names></name><name><surname>Nylund</surname><given-names>L</given-names></name><name><surname>Candela</surname><given-names>M</given-names></name><name><surname>Ostan</surname><given-names>R</given-names></name><name><surname>Bucci</surname><given-names>L</given-names></name><name><surname>Pini</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians</article-title>. <source/>PloS One
<year>2010</year>;<volume>5</volume>:<fpage>e10667</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0010667</pub-id><!--<pub-id pub-id-type="pmcid">2871786</pub-id>--><pub-id pub-id-type="pmid">20498852</pub-id></mixed-citation>
</ref>
<ref id="b77-jcp-23-117">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Bonafè</surname><given-names>M</given-names></name><name><surname>Valensin</surname><given-names>S</given-names></name><name><surname>Olivieri</surname><given-names>F</given-names></name><name><surname>De Luca</surname><given-names>M</given-names></name><name><surname>Ottaviani</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Inflamm–aging: an evolutionary perspective on immunosenescence</article-title>. <source/>Ann N Y Acad Sci
<year>2000</year>;<volume>908</volume>:<fpage>244</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2000.tb06651.x</pub-id><pub-id pub-id-type="pmid">10911963</pub-id></mixed-citation>
</ref>
<ref id="b78-jcp-23-117">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Nam</surname><given-names>RH</given-names></name><name><surname>Yoon</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name></person-group>
<article-title>Comparative analysis of ileal and cecal microbiota in aged rats</article-title>. <source/>J Cancer Prev
<year>2018</year>;<volume>23</volume>:<fpage>70</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.15430/JCP.2018.23.2.70</pub-id><!--<pub-id pub-id-type="pmcid">6037205</pub-id>--><pub-id pub-id-type="pmid">30003066</pub-id></mixed-citation>
</ref>
<ref id="b79-jcp-23-117">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>RH</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name></person-group>
<article-title>Microbial changes and host response in F344 rat colon depending on sex and age following a high-fat diet</article-title>. <source/>Front Microbiol
<year>2018</year>;<volume>9</volume>:<fpage>2236</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2018.02236</pub-id><!--<pub-id pub-id-type="pmcid">6160749</pub-id>--><pub-id pub-id-type="pmid">30298061</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-jcp-23-117" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>General mechanisms for microbiota-related colon cancer. Bacteria and their products affect the gut permeability to antigen. Dietary substrates undergo bacterial metabolism to form potentially carcinogenic products such as NOCs and secondary bile acids. Accordingly, chronic inflammation and genotoxicity contribute to the colon tumorigenesis. NOCs, N-nitroso compounds. Adapted from Sun and Kato.<xref ref-type="bibr" rid="b15-jcp-23-117">15</xref></p>
</caption>
<graphic xlink:href="jcp-23-117f1"></graphic>
</fig>
<fig id="f2-jcp-23-117" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Dietary compounds and the role of microbiota in colon carcinogenesis. Specific food compounds that are related to microbiota, and have a role in colon carcinogenesis, are shown. SCFAs, short-chain fatty acids; NOCs, N-nitroso compunds; ROS, reactive oxygen species. Adapted from Louis et al.<xref ref-type="bibr" rid="b29-jcp-23-117">29</xref> with original copyright holder’s permission.</p>
</caption>
<graphic xlink:href="jcp-23-117f2"></graphic>
</fig>
<table-wrap id="t1-jcp-23-117" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Key studies on butyrate and microbiota regarding colon cancer</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="bottom">Author (year)</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Study subject</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Protocol</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">Effect of butyrate on colon</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Whitehead et al. (1986)<xref ref-type="bibr" rid="b44-jcp-23-117">44</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell line LIM1215</td>
<td align="left" colspan="1" rowspan="1" valign="top">In vitro</td>
<td align="left" colspan="1" rowspan="1" valign="top">Differentiating effect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Freeman (1986)<xref ref-type="bibr" rid="b45-jcp-23-117">45</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Wistar rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">In vivo DMH</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enhancing the development of colonic neoplasia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Deschner et al. (1990)<xref ref-type="bibr" rid="b46-jcp-23-117">46</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">CF1 Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">In vivo AOM</td>
<td align="left" colspan="1" rowspan="1" valign="top">No difference in dysplasia or tumor</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Archer et al. (1998)<xref ref-type="bibr" rid="b47-jcp-23-117">47</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell line HT-29</td>
<td align="left" colspan="1" rowspan="1" valign="top">In vitro</td>
<td align="left" colspan="1" rowspan="1" valign="top">Growth inhibition</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Keefe et al. (2009)<xref ref-type="bibr" rid="b48-jcp-23-117">48</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cross-sectional</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher fecal butyrate in Native Africans</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Donohoe et al. (2011)<xref ref-type="bibr" rid="b49-jcp-23-117">49</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6 mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ex vivo CV vs. GF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stimulating colon epithelial cell proliferation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Furusawa et al. (2013)<xref ref-type="bibr" rid="b38-jcp-23-117">38</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice<xref ref-type="table-fn" rid="tfn2-jcp-23-117">a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">In vitro, in vivo</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inducing differentiation of colon Tregs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Belcheva et al. (2014)<xref ref-type="bibr" rid="b50-jcp-23-117">50</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">APC<sup>Min/+</sup>MSH2<sup>−−</sup> mice<xref ref-type="table-fn" rid="tfn3-jcp-23-117">b</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">In vivo</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inducing aberrant proliferation and transformation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Singh et al. (2014)<xref ref-type="bibr" rid="b40-jcp-23-117">40</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Niacr1<sup>−−</sup> mice<xref ref-type="table-fn" rid="tfn4-jcp-23-117">c</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">In vivo, ex vivo AOM + DSS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Suppressing colon inflammation and carcinogenesis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Humphreys et al. (2014)<xref ref-type="bibr" rid="b37-jcp-23-117">37</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Randomized trial</td>
<td align="left" colspan="1" rowspan="1" valign="top">Restoring oncogenic miRNA to baseline</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-jcp-23-117">
<p>DMH, 1,2-dimethylhydrazine; AOM, azoxymethane; CV, conventional; GF, germ-free; Tregs, regulatory T cells; DSS, dextran sulfate sodium; miRNA, microRNA.</p>
</fn>
<fn id="tfn2-jcp-23-117">
<label>a</label>
<p>GF IQI, C57BL/6 mice, Myd88<sup>−−</sup>Ticam1<sup>−−</sup> mice, OT-II transgenic mice.</p>
</fn>
<fn id="tfn3-jcp-23-117">
<label>b</label>
<p>C57BL/6J background.</p>
</fn>
<fn id="tfn4-jcp-23-117">
<label>c</label>
<p>C57BL/6 background.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>